Dimensional Fund Advisors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Dimensional Fund Advisors’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$227K	Sell	116,341 -29,981	-20%	-$61.1K	﹤0.01%	3061
2026 Q1	$360K	Sell	146,322 -2,130	-1%	-$7.13K	﹤0.01%	2988
2025 Q4	$591K	Buy	148,452 +49,676	+50%	+$220K	﹤0.01%	2944
2025 Q3	$373K	Buy	98,776 +40,418	+69%	+$137K	﹤0.01%	3037
2025 Q2	$141K	Hold	58,358	–	–	﹤0.01%	3153
2025 Q1	$48.1K	Hold	58,358	–	–	﹤0.01%	3261
2024 Q4	$49.6K	Hold	58,358	–	–	﹤0.01%	3292
2024 Q3	$72.4K	Hold	58,358	–	–	﹤0.01%	3265
2024 Q2	$97.5K	Sell	58,358 -2,049	-3%	-$3.66K	﹤0.01%	3253
2024 Q1	$112K	Buy	60,407 +24,284	+67%	+$44.8K	﹤0.01%	3246
2023 Q4	$68.6K	Hold	36,123	–	–	﹤0.01%	3320
2023 Q3	$47.7K	Hold	36,123	–	–	﹤0.01%	3385
2023 Q2	$108K	Sell	36,123 -7,790	-18%	-$25K	﹤0.01%	3310
2023 Q1	$152K	Buy	+43,913	New	+$213K	﹤0.01%	3249
2022 Q3	$194K	Buy	+48,437	New	+$367K	﹤0.01%	3242

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

AIHC Capital Management Central $104M AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors's NBP Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 20% in Q2 2026, selling an estimated $61.1K and leaving 116,341 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #3061.

Dimensional Fund Advisors first reported a position in NBP in Q3 2022 and has held it in 15 quarters since. The position peaked at $591K in Q4 2025. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

Dimensional Fund Advisors held 116,341 shares of NovaBridge Biosciences American Depositary Shares worth $227K as of Q2 2026.
Dimensional Fund Advisors sold 29,981 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $61.1K.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3061 holding.
Dimensional Fund Advisors first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2022 and has held it in 15 quarters since.
Dimensional Fund Advisors's NovaBridge Biosciences American Depositary Shares position peaked at $591K in Q4 2025.
49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.